Koselugo (selumetinib) has received the first approval for treatment of neurofibromatosis type 1 (NF1) in children ages 2 years and older, the U.S. Food and...
The American College of Radiology® (ACR®) today released an update to its ACR Appropriateness Criteria®, which includes 193 diagnostic imaging and interventional radiology topics...